Primary Site >> Liver Cancer
Gene >> IRAK1
| 1. | |||||||||||
| Journal: | J Hepatol. 2011 Jan;54(1):26-33. | ||||||||||
| Title: | Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. | ||||||||||
| Author: | Xiang, Wen-Qing|Feng, Wen-Feng|Ke, Wei|Sun, Zhen|Chen, Zhi|Liu, Wei | ||||||||||
| PMID: | 20937539 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Cell Biochem. 2011 Jul;353(1-2):151-7. | ||||||||||
| Title: | Alterations in the expression of genes related to NF-kappaB signaling in liver and kidney of CuZnSOD-deficient mice. | ||||||||||
| Author: | Brzoska, Kamil|Sochanowicz, Barbara|Siomek, Agnieszka|Olinski, Ryszard|Kruszewski, Marcin | ||||||||||
| PMID: | 21472504 | ||||||||||
| 3. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11455-60. | ||||||||||
| Title: | Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. | ||||||||||
| Author: | Hartwell, Hadley J|Petrosky, Keiko Y|Fox, James G|Horseman, Nelson D|Rogers, Arlin B | ||||||||||
| PMID: | 25049387 | ||||||||||
| 4. | |||||||||||
| Journal: | J Clin Invest. 2015 Nov 2;125(11):4239-54. | ||||||||||
| Title: | STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma. | ||||||||||
| Author: | Li, Weiyun|Xiao, Jun|Zhou, Xin|Xu, Ming|Hu, Chaobo|Xu, Xiaoyan|Lu, Yao|Liu, Chang|Xue, Shengjie|Nie, Lei|Zhang, Haibin|Li, Zhiqi|Zhang, Yanbo|Ji, Fu|Hui, Lijian|Tao, Wufan|Wei, Bin|Wang, Hongyan | ||||||||||
| PMID: | 26457732 | ||||||||||
| 5. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Mar 21;10:1711-1723. | ||||||||||
| Title: | Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas. | ||||||||||
| Author: | Ye, Zhi-Hua|Gao, Li|Wen, Dong-Yue|He, Yun|Pang, Yu-Yan|Chen, Gang | ||||||||||
| PMID: | 28356759 | ||||||||||
| 6. | |||||||||||
| Journal: | Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1301-1313. | ||||||||||
| Title: | Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma. | ||||||||||
| Author: | Zamani, Parvin|Matbou Riahi, Maryam|Momtazi-Borojeni, Amir Abbas|Jamialahmadi, Khadijeh | ||||||||||
| PMID: | 29025272 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Res. 2018 May 1;78(9):2332-2342. | ||||||||||
| Title: | IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma. | ||||||||||
| Author: | Cheng, Bowie Y|Lau, Eunice Y|Leung, Hoi-Wing|Leung, Carmen Oi-Ning|Ho, Nicole P|Gurung, Shilpa|Cheng, Lily K|Lin, Chi Ho|Lo, Regina Cheuk-Lam|Ma, Stephanie|Ng, Irene Oi-Lin|Lee, Terence K | ||||||||||
| PMID: | 29483095 | ||||||||||
| 8. | |||||||||||
| Journal: | J Exp Pharmacol. 2018 May 9;10:9-17. | ||||||||||
| Title: | Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. | ||||||||||
| Author: | Al-Fayoumi, Suliman|Hashiguchi, Taishi|Shirakata, Yuka|Mascarenhas, John|Singer, Jack W | ||||||||||
| PMID: | 29785143 | ||||||||||
| 9. | |||||||||||
| Journal: | Biomed Res Int. 2018 Jul 9;2018:1252849. | ||||||||||
| Title: | Functional Polymorphisms in IRAKs Are Related to Hepatocellular Carcinoma Risk in Chinese Population. | ||||||||||
| Author: | Wang, Hui|Song, Ci|Qi, Qi|Huang, Tongtong|Wang, Lijuan|Chen, Jianguo|Zhu, Jian|Hu, Zhibin|Dai, Juncheng | ||||||||||
| PMID: | 30112356 | ||||||||||
| 10. | |||||||||||
| Journal: | J Leukoc Biol. 2018 Aug 26. | ||||||||||
| Title: | Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets. | ||||||||||
| Author: | Kirchmeyer, Melanie|Servais, Florence A|Hamdorf, Matthias|Nazarov, Petr V|Ginolhac, Aurelien|Halder, Rashi|Vallar, Laurent|Glanemann, Matthias|Rubie, Claudia|Lammert, Frank|Kreis, Stephanie|Behrmann, Iris | ||||||||||
| PMID: | 30145833 | ||||||||||